Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years

Background There are two distinct phenotypes of multiple sclerosis (MS) in Asians, manifesting as optic-spinal (OSMS) and conventional (CMS) forms. In Japan, four nationwide surveys of MS have been conducted. The first three were in 1972, 1982, and 1989, and we performed the fourth in 2004. Results The recent survey showed six main findings as follows: (1) a four-fold increase in the estimated number of clinically definite patients with MS in 2003 (9900; crude MS prevalence, 7.7/100,000) compared with 1972; (2) a shift in the peak age at onset from early 30s in 1989 to early 20s in 2003; (3) a successive proportional decrease in optic-spinal involvement in clinically definite patients with MS; (4) a significant north–south gradient for the CMS/OSMS ratio; (5) after subdivision of the mainland (30–45° North) into northern and southern parts at 37°N, northern-born northern residents (northern patients) showed a significantly higher CMS/OSMS ratio and higher frequency of brain lesions fulfilling the Barkhof criteria (Barkhof brain lesions) than southern-born southern residents (southern patients); (6) among northern patients, the absolute numbers of patients with CMS and those with Barkhof brain lesions rapidly increased with advancing birth year. Conclusions These findings suggest that MS phenotypes are drastically altered by environmental factors, such as latitude and “Westernization.”

[1]  F. Mihara,et al.  Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. , 2007, Brain : a journal of neurology.

[2]  A. Compston.  Complexity and heterogeneity in demyelinating disease. , 2007, Brain : a journal of neurology.

[3]  K. Tanaka,et al.  Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions , 2007, Multiple sclerosis.

[4]  W. Valdar,et al.  Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.

[5]  J. Kira,et al.  Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: Positive correlation with disease severity , 2006, Journal of Neuroimmunology.

[6]  F. Mihara,et al.  Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings , 2006, Journal of the Neurological Sciences.

[7]  B. Banwell,et al.  Age at Onset of Multiple Sclerosis May Be Influenced by Place of Residence during Childhood Rather than Ancestry , 2006, Neuroepidemiology.

[8]  Y. Itoyama,et al.  Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  K. Fujihara,et al.  OSMS is NMO, but not MS: proven clinically and pathologically , 2006, The Lancet Neurology.

[10]  S. Olindo,et al.  Role of return migration in the emergence of multiple sclerosis in the French West Indies. , 2005, Brain : a journal of neurology.

[11]  S. Kikuchi,et al.  “OSMS is NMO, but not MS”: confirmed by NMO-IgG? , 2005, The Lancet Neurology.

[12]  Y. Itoyama,et al.  Interferon beta-1b is effective in Japanese RRMS patients , 2005, Neurology.

[13]  J L Haines,et al.  Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis , 2004, Neurology.

[14]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[15]  P. Contu,et al.  Anticipation of age at onset in multiple sclerosis , 2004, Neurology.

[16]  K. Tokunaga,et al.  Genetic origins of the Ainu inferred from combined DNA analyses of maternal and paternal lineages , 2004, Journal of Human Genetics.

[17]  F. Barkhof,et al.  Spinal cord abnormalities in recently diagnosed MS patients , 2004, Neurology.

[18]  M. Wallin,et al.  Multiple sclerosis in US veterans of the Vietnam era and later military service: Race, sex, and geography , 2004, Annals of neurology.

[19]  K. Kikuchi,et al.  Prevalence of multiple sclerosis in Asahikawa, a city in northern Japan , 2003, Journal of the Neurological Sciences.

[20]  S. Kikuchi,et al.  The prevalence and clinical characteristics of MS in northern Japan , 2003, Journal of the Neurological Sciences.

[21]  J. Kira.  Multiple sclerosis in the Japanese population , 2003, The Lancet Neurology.

[22]  P. Contu,et al.  Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study , 2002, The Lancet.

[23]  A. Matsumori,et al.  Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey , 2002, Heart.

[24]  J. Anaya,et al.  Clinical features of multiple sclerosis in a genetically homogeneous tropical population , 2001, Multiple sclerosis.

[25]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[26]  J. Granados,et al.  HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis , 2000, Neurology.

[27]  D. English,et al.  The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. , 2000, Brain : a journal of neurology.

[28]  K. Tokunaga,et al.  Analysis of HLA genes and haplotypes in Ainu (from Hokkaido, northern Japan) supports the premise that they descent from Upper Paleolithic populations of East Asia. , 2000, Tissue antigens.

[29]  P C O'Brien,et al.  The clinical course of neuromyelitis optica (Devic’s syndrome) , 1999, Neurology.

[30]  F. Mihara,et al.  HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. , 1999, Brain : a journal of neurology.

[31]  J. Kira,et al.  Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan , 1999, Journal of the Neurological Sciences.

[32]  Y. Itoyama,et al.  Decrease in multiple sclerosis with acute transverse myelitis in Japan. , 1999, The Tohoku journal of experimental medicine.

[33]  M. Elian,et al.  Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis , 1997, Journal of neurology, neurosurgery, and psychiatry.

[34]  G. Comi,et al.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.

[35]  A. Compston.  Genetic epidemiology of multiple sclerosis. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[36]  Shozo Tobimatsu,et al.  Western versus asian types of multiple sclerosis: Immunogenetically and clinically distinct disorders , 1996, Annals of neurology.

[37]  R. Knobler,et al.  Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. , 1995, Radiology.

[38]  H. Yanagawa,et al.  [A method of interval estimation for number of patients in the nationwide epidemiological survey on intractable diseases]. , 1991, [Nihon koshu eisei zasshi] Japanese journal of public health.

[39]  G. Dean,et al.  Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[40]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[41]  R. Detels,et al.  Multiple sclerosis and age at migration. , 1978, American journal of epidemiology.

[42]  H. Shibasaki,et al.  Nationwide survey of multiple sclerosis in Japan Clinical analysis of 1,084 cases , 1975, Neurology.

[43]  H. Shibasaki,et al.  Clinical studies of multiple sclerosis in Japan , 1973, Neurology.

[44]  L. Kurland,et al.  Mortality and migration in multiple sclerosis , 1971, Neurology.

[45]  Osuntokun Bo.  The pattern of neurological illness in tropical Africa , 1971 .

[46]  F. Mcdowell,et al.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS , 1965, Annals of the New York Academy of Sciences.

[47]  Y. Kuroiwa,et al.  Multiple sclerosis and allied diseases in Japan , 1958, Neurology.

[48]  P. Macaskili,et al.  Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study , 2007 .

[49]  A. Compston,et al.  Multiple sclerosis. , 2002, Lancet.

[50]  S. Reingold,et al.  Prevalence estimates for MS in the United States and evidence of an increasing trend for women , 2002, Neurology.

[51]  H. Yanagawa,et al.  Response Bias in the Nationwide Epidemiological Survey of an Intractable Disease in Japan , 1991 .

[52]  B. Osuntokun.  The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria. , 1971, Journal of the neurological sciences.